Bleeding proximal vs distal to the ligament of Treitz — resuscitate first, localize next, then targeted endoscopic or angiographic therapy.
Also known as: GI bleed, upper GI bleed, UGIB, lower GI bleed, LGIB, hematemesis, melena, hematochezia
Overview
Acute or chronic blood loss from the gastrointestinal tract. Upper GI bleeding (UGIB) originates proximal to the ligament of Treitz and presents most commonly with hematemesis, coffee-ground emesis, or melena. Lower GI bleeding (LGIB) originates distal to the ligament of Treitz and most commonly presents as hematochezia or maroon stool. Obscure GI bleeding refers to bleeding with negative initial upper and lower endoscopy.
Epidemiology
UGIB: ~100 per 100,000 adults per year; mortality 2-10%. Peptic ulcer disease accounts for ~30-50% of UGIB, variceal bleeding ~10-20%. LGIB: ~20-30 per 100,000 per year; diverticular bleeding is the most common cause in adults (30-50%), followed by angiodysplasia, colitis (ischemic, infectious, IBD), neoplasm, and hemorrhoids. Both are more common in older adults and patients on antiplatelets/anticoagulants.
Try two board-style Upper and Lower GI Bleeding questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1GastrointestinalMedium
A 55-year-old male has an upper GI bleed. Esophagogastroduodenoscopy (EGD) shows a duodenal ulcer with a visible vessel (Forrest IIa). IV proton pump inhibitor (PPI) is started. Which of the following is the most appropriate next step in endoscopic management?
AEndoscopic injection sclerotherapy
BHemostatic clip plus epinephrine injection
CTopical hemostatic powder application
DArgon plasma coagulation monotherapy
Reveal answer & full explanation
Correct answer: B — Hemostatic clip plus epinephrine injection
AEndoscopic injection sclerotherapy
BHemostatic clip plus epinephrine injection✓
CTopical hemostatic powder application
DArgon plasma coagulation monotherapy
Why Hemostatic clip plus epinephrine injection is correct
Forrest IIa (non-bleeding visible vessel) is a high-risk stigma that requires endoscopic hemostasis.
Combination therapy — epinephrine injection plus a second modality such as a hemostatic clip or thermal coagulation — is superior to epinephrine injection alone.
Epinephrine alone is inadequate; the mechanical/thermal component provides durable hemostasis of the vessel.
Why the others are wrong
Endoscopic injection sclerotherapy — a technique for esophageal/gastric varices, not bleeding peptic ulcers (right-concept-wrong-lesion).
Topical hemostatic powder application — a temporizing rescue measure that sloughs off the mucosa within 24-72 hours; it does not durably obliterate an exposed visible vessel (right-concept-wrong-durability).
Argon plasma coagulation monotherapy — thermal monotherapy that is less durable for a visible vessel than dual therapy (single-modality trap).
Additional high-yield points
Post-endoscopy proton pump inhibitor (PPI): IV infusion (80 mg bolus then 8 mg/hr for 72 hours) reduces rebleeding and mortality; transition to oral PPI BID after 72 hours.
H. pylori testing and eradication is mandatory in all peptic ulcer disease (PUD); eradication reduces recurrence from ~80% to <10%.
Question 2GastrointestinalMedium
A 71-year-old man is brought to the emergency department after two episodes of coffee-ground emesis followed by a black, tarry stool. He reports several weeks of epigastric burning. He has osteoarthritis of both knees, for which he takes high-dose ibuprofen most days, and mild diet-controlled type 2 diabetes. He drinks one beer on weekends and does not smoke. On exam he is pale; heart rate is 104/min and blood pressure is 118/72 mm Hg. Stool is melenic on rectal exam, and the BUN:creatinine ratio is 38. Of the elements in his history, which of the following is the strongest risk factor for his upper gastrointestinal bleed?
AChronic osteoarthritis pain
BType 2 diabetes mellitus
CDaily high-dose NSAID use
DAdvanced age over 70 years
Reveal answer & full explanation
Correct answer: C — Daily high-dose NSAID use
AChronic osteoarthritis pain
BType 2 diabetes mellitus
CDaily high-dose NSAID use✓
DAdvanced age over 70 years
Why Daily high-dose NSAID use is correct
Peptic ulcer disease causes 30-50% of upper GI bleeds, and chronic NSAID/aspirin use is the dominant modifiable driver: NSAIDs inhibit COX-1-mediated prostaglandin synthesis, stripping the gastroduodenal mucosa of its protective mucus/bicarbonate layer and promoting acid-peptic erosion of submucosal vessels.
This patient's high-dose daily ibuprofen, antecedent epigastric burning, melena, and BUN:Cr ratio greater than 30 all point to an NSAID-related bleeding ulcer.
Guideline management (ACG 2021) is IV PPI, EGD within 24 hours with endoscopic hemostasis for high-risk stigmata, H. pylori testing/eradication, and NSAID avoidance.
Why the others are wrong
Type 2 diabetes mellitus is a comorbidity that can worsen outcomes but is not an established independent risk factor for upper GI bleeding; it does not erode mucosa.
Chronic osteoarthritis pain — the arthritis is the indication for treatment rather than the exposure that injures the gut; the mucosal damage comes from COX-1 inhibition by the ibuprofen taken for it, so the drug and not the pain is the risk factor.
Advanced age over 70 years is a real but comparatively weak, non-modifiable risk factor; it amplifies risk mainly through accumulated comorbidity and antithrombotic use rather than directly causing the lesion.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Upper and Lower GI Bleeding (Approach and Management) outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Both: age >65, antithrombotic therapy, chronic kidney disease, coagulopathy
Pathophysiology
Bleeding sources reflect underlying mechanisms: erosion of a vessel by acid-peptic injury (PUD), rupture of submucosal varices in portal hypertension, Mallory-Weiss tears, vascular malformations (angiodysplasia, Dieulafoy), diverticular vessel erosion (LGIB), inflammatory or neoplastic ulceration, ischemic injury, and post-procedural bleeding. Hemodynamic compromise depends on volume and rate of bleeding plus patient reserve.
Clinical presentation
Symptoms
Hematemesis (bright red or coffee-ground) — UGIB
Melena (black, tarry, foul-smelling stool) — usually UGIB, occasionally right-sided LGIB if slow
Hematochezia (bright red blood per rectum) — usually LGIB, but brisk UGIB can also produce hematochezia
Maroon stool — distal small bowel or proximal colon
Lightheadedness, syncope, dyspnea, fatigue from anemia
Pre-syncope, exertional intolerance with chronic bleeding
Signs / physical exam
Tachycardia, orthostatic hypotension (~15% blood loss), frank hypotension (~30% loss)
Pallor, cool/clammy skin
Abdominal tenderness suggests inflammation, ischemia, or perforation (rare in pure UGIB/LGIB)
Stigmata of chronic liver disease (spider angiomata, palmar erythema, caput medusae, ascites)
DRE: gross blood, melena, palpable mass
Classic findings
BUN:Creatinine ratio >30 (in absence of CKD) strongly suggests upper GI source from absorbed blood proteins; orthostatic vital signs help estimate volume loss.
Differential diagnosis
Upper GI bleed: peptic ulcer disease — NSAID use, H. pylori, epigastric pain, melena ± hematemesis; treat with PPI and EGD
Upper GI bleed: variceal hemorrhage — Cirrhosis or portal hypertension; large-volume hematemesis; octreotide + band ligation + antibiotics
Upper GI bleed: Mallory-Weiss tear — Vomiting then hematemesis; usually self-limited
Upper GI bleed: Dieulafoy lesion — Submucosal artery, often gastric fundus; recurrent painless bleeding
Upper GI bleed: aortoenteric fistula — History of aortic graft or AAA; herald sentinel bleed precedes massive hemorrhage
Upper GI bleed: malignancy (esophageal, gastric) — Weight loss, anemia, chronic blood loss
Lower GI bleed: diverticular bleeding — Painless brisk hematochezia in elderly; usually right-sided; stops spontaneously in 75%
Lower GI bleed: angiodysplasia — Painless intermittent bleeding; older adults, CKD, aortic stenosis; right colon
Lower GI bleed: colitis (ischemic, infectious, IBD) — Diarrhea, abdominal pain, fever; mucosal inflammation on endoscopy
Lower GI bleed: colorectal neoplasm — Chronic occult or overt bleeding, weight loss, change in bowel habits
Lower GI bleed: hemorrhoidal/anorectal — Bright red on toilet paper, painless (internal) or painful (thrombosed external)
Diagnostic workup
Labs
CBC (initial Hgb may not reflect acute loss until reequilibration), BMP (BUN/Cr ratio), LFTs, coagulation studies (PT/INR, PTT), type and crossmatch ≥2 units
Lactate if hemodynamically unstable
Pregnancy test in women of reproductive age
Stool studies if infectious colitis suspected
Imaging
Upper endoscopy (EGD): within 24 h for UGIB (within 12 h if hemodynamically unstable or variceal suspicion)
Colonoscopy: after adequate bowel preparation for LGIB; ideally within 24 h once stabilized
CT angiography: for active brisk bleeding, especially when endoscopy is nondiagnostic or impractical; localizes bleeding ≥0.3-0.5 mL/min
Tagged RBC scan: detects slower bleeding (~0.1 mL/min) but less precise for localization
Conventional angiography with embolization: therapeutic for arterial bleeding when endoscopy fails or patient unstable
Push enteroscopy, video capsule endoscopy, or deep enteroscopy (single/double balloon) for obscure or small bowel sources
Meckel scan (technetium pertechnetate) in young patients with obscure bleeding
Diagnostic algorithm
flowchart TD
A[Suspected GI bleed] --> B[ABCs + 2 large-bore IVs<br/>type and cross, labs, NPO]
B --> C[Resuscitate with crystalloid<br/>transfuse to Hgb ≥7 g/dL<br/>correct coagulopathy / reverse anticoagulant]
C --> D{Upper vs lower source?<br/>Hematemesis, melena, BUN:Cr >30 = upper}
D -->|Upper| E[IV PPI<br/>± octreotide + ceftriaxone if variceal]
E --> F[EGD within 12-24 h<br/>endoscopic hemostasis<br/>combination therapy for high-risk stigmata]
F --> G{Hemostasis<br/>achieved?}
G -->|No| H[Angiographic embolization<br/>or surgery; TIPS for varices]
G -->|Yes| I[H. pylori test, PPI,<br/>NSAID counseling, beta-blocker if varices]
D -->|Lower stable| J[Rapid bowel prep<br/>+ colonoscopy ≤24 h]
J --> K[Endoscopic therapy<br/>treat underlying cause]
D -->|Lower unstable / brisk hematochezia| L[CTA → angiography<br/>with embolization]
L --> M{Failed?}
M -->|Yes| N[Surgical resection<br/>subtotal colectomy if source unknown]
Unified approach to acute upper and lower GI bleeding.
Complications
Hemorrhagic shock and multiorgan failure
Aspiration pneumonia
Rebleeding (UGIB rebleed ~10-20% depending on lesion)
Myocardial infarction from demand ischemia
Acute kidney injury
Transfusion-related reactions, TACO, TRALI
Hospital-acquired infections
Death (overall mortality 2-10% UGIB, 2-4% LGIB; higher with variceal hemorrhage and comorbidities)
PANCE pearls
Resuscitate first, localize later — fluid + blood + correct coagulopathy before endoscopy whenever possible.
BUN:Cr >30 (without CKD) points to an upper source; do NG lavage only if needed for visualization, not for diagnosis.
Brisk upper GI bleeding (massive) can present as hematochezia — get EGD first when in doubt with hemodynamic instability.
Variceal bleed cocktail: octreotide + ceftriaxone + early EGD with band ligation; consider TIPS for refractory bleeding.
Restrictive transfusion (target Hgb ≥7) improves outcomes in stable UGIB; do not over-transfuse variceal patients (raises portal pressure and worsens bleeding).
References
ACG 2021 UGIB — ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding (Laine et al., Am J Gastroenterol 2021)
ACG 2023 LGIB — ACG Clinical Guideline: Management of Patients with Acute Lower Gastrointestinal Bleeding (Sengupta et al., Am J Gastroenterol 2023)
AASLD 2017 — AASLD Practice Guidance on Portal Hypertensive Bleeding in Cirrhosis (Garcia-Tsao et al., Hepatology 2017/2024 update)
ESGE 2021 — European Society of Gastrointestinal Endoscopy guideline: diagnosis and management of non-variceal upper GI hemorrhage
Practice Gastrointestinal questions on FirstPassPA
Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.